Effect of alternate-day steroids on renal transplant function. A controlled study

Area of Science:

• Nephrology
• Immunosuppression Therapy
• Transplantation Medicine

Background:

• Renal transplant recipients often require long-term immunosuppression.
• Prednisone is a common corticosteroid used in post-transplant care.
• Optimizing prednisone dosing is crucial to balance efficacy and minimize side effects.

Purpose of the Study:

• To evaluate the efficacy and safety of alternate-day prednisone compared to daily prednisone in renal transplant recipients.
• To determine if alternate-day dosing impacts graft rejection, renal function, or adverse events.

Main Methods:

• A randomized, controlled study involving 53 renal transplant recipients.
• Patients were followed for 610 patient-months.
• Comparison between alternate-day and daily prednisone groups, stratified by related and cadaver donor organs.

Main Results:

• No significant differences were observed in rejection rates per patient month between alternate-day and daily prednisone groups.
• Changes in serum creatinine, azathioprine dosage, prednisone dosage, and weight did not differ significantly.
• Blood pressure changes, resolution of Cushingoid features, and development of posterior subcapsular cataracts were similar across groups.

Conclusions:

• Alternate-day prednisone therapy is a viable alternative to daily dosing in renal transplant recipients.
• This dosing strategy appears to offer comparable efficacy and safety profiles.
• Further research may explore long-term outcomes and patient adherence with alternate-day regimens.